Skip to main content
Clinical Trials/NL-OMON26955
NL-OMON26955CompletedNot Applicable

Patient-controlled remifentanil analgesia during oocyte retrieval for IVF/ICSI procedures.

VU University Medical Center0 sites78 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
78

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Female subjects who undergo elective IVF/ICSI;
  • 2. Age 18-45 years;

Exclusion Criteria

  • 1. Not willing to receive analgesia;
  • 2. Allergy for remifentanil or pethidine.

Investigators

Sponsor
VU University Medical Center

Similar Trials

Patient-controlled remifentanil analgesia... | Clinical Trial